Mir210tm1.1Wtsi
Targeted Allele Detail
|
|
| Symbol: |
Mir210tm1.1Wtsi |
| Name: |
microRNA 210; targeted mutation 1.1, Wellcome Trust Sanger Institute |
| MGI ID: |
MGI:5555932 |
| Synonyms: |
Mir210tm1.1(mirKO)Wtsi |
| Gene: |
Mir210 Location: Chr7:140801297-140801406 bp, - strand Genetic Position: Chr7, 86.52 cM
|
| Alliance: |
Mir210tm1.1Wtsi page
|
|
| Mutant Cell Line: |
mirKO_ES_PuDtk_1A1 |
| Germline Transmission: |
Earliest citation of germline transmission:
J:205868
|
| Parent Cell Line: |
JM8.F6 (ES Cell)
|
| Strain of Origin: |
C57BL/6N
|
|
| Allele Type: |
|
Targeted (Null/knockout) |
| Mutation: |
|
Insertion
Vector: PGK_EM7_PuDtk_bGHpA
|
| |
|
Mutation details: The insertion of the PGK_EM7_PuDtk_bGHpA cassette created a deletion of size 237 starting at position 148407458 and ending at position 148407221 of Chromosome 7 (Genome Build 37). This deletion eliminates the DNA sequence for this microRNA. The cassette is composed of a loxP site followed by an F3 site followed by a PGK-puromycin-delta-tk cassette, a loxP site and finally an FRT site. Cre-mediated recombination removed the selection cassette.
(J:205868)
|
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
|
|
| Original: |
J:205868 Mok Y, et al., MiR-210 is induced by Oct-2, regulates B cells, and inhibits autoantibody production. J Immunol. 2013 Sep 15;191(6):3037-48 |
| All: |
3 reference(s) |
|